Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 17Sarcoma 11Lymphoid 1Head & Neck 1

Conditions

Lymphoma, Large B-Cell, Diffuse 39Lymphoma 34Lymphoma, Follicular 24Lymphoma, Non-Hodgkin 23Lymphoma, Mantle-Cell 19Lymphoma, B-Cell 16Leukemia, Lymphocytic, Chronic, B-Cell 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Multiple Myeloma 15Burkitt Lymphoma 14Lymphoma, B-Cell, Marginal Zone 13Hodgkin Disease 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Large-Cell, Anaplastic 8Glioma 8Neuroectodermal Tumors, Primitive, Peripheral 7Neuroblastoma 7Mycosis Fungoides 7Lymphoma, T-Cell 7Histiocytosis, Langerhans-Cell 7Wilms Tumor 6Waldenstrom Macroglobulinemia 6Sarcoma 6Rhabdoid Tumor 6Medulloblastoma 6Lymphoma, T-Cell, Cutaneous 6Hepatoblastoma 6Ependymoma 6Rhabdomyosarcoma 5Osteosarcoma 5

Interventions

Filgrastim 4Temozolomide 2Psychiatric Rehabilitation 2Cyproheptadine 2Carmustine 2Bortezomib 2varlilumab 1trametinib 1sonidegib 1sargramostim 1ribociclib 1poly ICLC 1ixabepilone 1imetelstat 1exatecan 1etoposide phosphate 1entinostat 1carboxyamido-triazole 1becatecarin 1Vorinostat 1Transurethral Resection of Bladder 1Topotecan 1Thiotepa 1Thalidomide 1Spinal Puncture 1Specimen Handling 1Radiotherapy 1Postoperative Period 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oligodendroglioma × Magnetic Resonance Spectroscopy × Lymphoid × Clear all
NCT07468136 2026-04-13

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Mayo Clinic

Phase 1/2 Not yet recruiting
33 enrolled
CNSLymphoid

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡